RxSight, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-6.1M | $-9.1M | $-9.2M | $-12.4M | $-13.8M | $-13.2M | $-15.6M | $-16.8M |
| Depreciation & Amortization | $812.0K | $1.1M | $1.1M | $1.1M | $989.0K | $955.0K | $918.0K | $941.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $6.1M | $4.7M | $4.4M | $4.1M | $4.0M | $3.3M | $3.0M | $2.9M |
| Net Cash from Operating Activities | $-4.0M | $-9.3M | $-8.3M | $-8.0M | $-7.5M | $-17.8M | $-13.9M | $-15.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.5M | $2.0M | $1.6M | $653.0K | $1.8M | $747.0K | $362.0K | $580.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-115.6M | $24.3M | $4.6M | $17.3M | $4.4M | $-48.4M | $10.4M | $560.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $111.5M | $8.0M | $3.6M | $-8.2M | $891.0K | $65.3M | $6.3M | $-455.0K |
| Net Change in Cash | $-8.2M | $23.0M | $-166.0K | $1.1M | $-2.3M | $-822.0K | $2.9M | $-15.1M |
| Free Cash Flow | $-5.6M | $-11.3M | $-9.9M | $-8.6M | $-9.4M | $-18.5M | $-14.2M | $-15.8M |